stockrow
Friday 6 November 2026
Export PNTG’s income statement to Excel — free account
The Pennant Group, Inc.
PNTG Healthcare Medical Care Facilities
The Pennant Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $947.7 million, up 36.3% from fiscal 2024.
- Revenue
- +32.0%
- EPS
- +55.6%
- Free cash flow
- −3.19%
- Total debt
- +662.8%
Quarter to September 2026, against a year earlier
36.58
3.42
−8.55%
Follow PNTG
Alert me
| Sep '26 From the 10-Q filed 4 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
37.50 | 39.31 | 34.25 | 32.36 |
+8 more quarters Free account |
P/S ratio |
1.16 | 1.17 | 1.03 | 1.03 | |
P/FCF ratio |
39.74 | 37.11 | 20.85 | 26.84 | |
P/Operating CF |
54.34 | 58.96 | (310.85) | 46.42 | |
P/B ratio |
3.25 | 3.18 | 2.72 | 2.60 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.32 | 1.33 | 1.20 | 1.19 | |
EV/EBITDA |
18.99 | 20.02 | 18.32 | 18.43 | |
EV/Operating CF |
23.95 | 27.57 | 18.50 | 23.39 | |
EV/FCF |
44.98 | 42.36 | 24.09 | 31.16 | |
Quick Ratio |
0.98 | 0.97 | 0.99 | 0.95 | |
Current Ratio |
1.18 | 1.20 | 1.19 | 1.14 | |
Net Debt/EBITDA |
8.78 | 8.85 | 8.15 | 7.81 | |
Debt/Assets |
19.02% | 19.04% | 17.74% | 17.96% | |
Debt/Equity |
0.47 | 0.49 | 0.44 | 0.46 | |
Asset Turnover |
1.31 | 1.23 | 1.20 | 1.15 | |
Operating CF/Net income |
2.61 | 2.40 | (0.40) | 2.43 | |
Capex/Depreciation |
(3.76) | (1.86) | (1.80) | (1.37) | |
Interest Coverage |
4.56 | 5.13 | 5.64 | 5.37 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.83% | 7.25% | 6.90% | 6.69% | |
Intangible Assets out of Total Assets |
0.42 | 0.42 | 0.46 | 0.45 | |
Share Based Compensation of Revenue |
1.10% | 0.99% | 0.88% | 0.75% | |
Graham Net Nets |
(0.33) | (0.35) | (0.39) | (0.44) | |
Graham Number |
16.75 | 15.67 | 14.99 | 14.56 | |
Earnings Yield |
2.67% | 2.54% | 2.92% | 3.09% | |
Free Cash Flow Yield |
2.52% | 2.69% | 4.80% | 3.73% | |
Revenue per Share |
8.64 | 8.55 | 8.22 | 8.37 | |
Operating CF per Share |
0.72 | 0.63 | (0.10) | 0.61 | |
Capex per Share |
(0.43) | (0.18) | (0.15) | (0.10) | |
Free Cash Flow per Share |
0.29 | 0.44 | (0.25) | 0.50 | |
Cash per Share |
0.53 | 0.44 | 0.14 | 0.49 | |
Shareholders Equity per Share |
11.99 | 11.61 | 11.21 | 10.83 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
11.99 | 11.61 | 11.21 | 10.83 | |
Free Cash Flow |
10.13 | 15.49 | (8.67) | 17.40 | |
Working Capital |
27.34 | 31.19 | 24.25 | 20.14 | |
Capital Expenditures |
(14.99) | (6.34) | (5.27) | (3.56) | |
Net Current Asset Value |
(443.98) | (449.26) | (414.22) | (426.52) | |
EV/EBIT |
22.57 | 23.63 | 21.64 | 21.77 | |
Capex to Sales |
0.05 | 0.02 | 0.02 | 0.01 | |
Price to Operating Income |
19.94 | 20.70 | 18.72 | 18.75 | |
| Other line items | |||||
Average Receivables |
113.46 | 114.45 | 108.91 | 102.21 | |
Average Payables |
24.58 | 22.73 | 20.80 | 21.95 | |
Average Assets |
898.23 | 894.35 | 850.05 | 823.85 | |
Average Common Equity |
381.40 | 369.03 | 356.23 | 343.11 |
Columns are period end dates · fundamentals updated 4 Nov 2026